Survey on Itch in Outpatients of a University Clinic

Completed

• Conditions: Itch

• Registration Number: NCT03901443
• Lead Sponsor: University Hospital, Basel, Switzerland

Brief Summary

This study is to investigate the pruriception (i.e. the perception of the character and intensity of itch), the impact of itch on quality of life, the response to itch and the subjective efficacy and preferences of the different treatment options among patients with different skin diseases. Better insights into these aspects might help to optimize itch treatment in clinical Settings.

Detailed Description

Not available

Study Timeline

• Study Start: 2015-12-09
• Primary Completion: 2016-04-30
• Study Completion: 2016-04-30
• Status Verified: 2019-04
• Study First Submitted: 2019-04-01
• Study First Submitted QC: 2019-04-02
• Study First Posted: 2019-04-03
• Last Update Submitted: 2019-04-04
• Last Update Posted: 2019-04-08

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

• outpatients suffering from itch

Exclusion Criteria

• outpatients (suffering from itch) not willing or able to participate

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
itch perception	single time point assessment at baseline	Questions regarding situations in which the itch is especially bad (multiple choice options regarding day time, daily situations, season); objective assessment in which respondents are asked to select answers from the choices offered as a list
quality of sleep	single time point assessment at baseline	Questions regarding sleep disturbance by itch (Does itch disturb the patient's sleep and/or sleep of other persons? (yes/no))
days missing at work	single time point assessment at baseline	Approximate number of days missing at work due to itch within last 6 months
helpfulness of common itch therapies	single time point assessment at baseline	Questions regarding helpfulness of common itch therapies (NRS 0-10; 0 = no reduction in itch, 10; = complete reduction of itch; additionally free text options to indicate specific creams, tablets or alternative medicine)
itch intensity	single time point assessment at baseline	Questions regarding itch perception (NRS 0-10; 0 = no itch, 10 = worst imaginable itch) experienced at the moment, within the last 7 days, within the last month
impact of itch on quality of life	single time point assessment at baseline	Questions regarding strength of impact of itch on quality of life (NRS 0-10; 0 = no impact, 10 = extreme)
preferred treatment options	single time point assessment at baseline	Questions regarding preferred treatment options (NRS 0- 10; 0 = unimportant, 10 = most important; including additional free text option)

Trial Locations

Locations (1)

Department of Dermatology, University Hospital Basel; 🇨🇭 Basel, Switzerland